List of Tables
Table 1. Global Epilepsy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Partial/focal Seizure
Table 3. Key Players of Generalized Seizure
Table 4. Key Players of Myoclonus Misses
Table 5. Key Players of Negative Myoclonus
Table 6. Key Players of Eyelid Myoclonus
Table 7. Key Players of Laughter
Table 8. Key Players of Others
Table 9. Global Epilepsy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Epilepsy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Epilepsy Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Epilepsy Market Share by Region (2018-2023)
Table 13. Global Epilepsy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Epilepsy Market Share by Region (2024-2029)
Table 15. Epilepsy Market Trends
Table 16. Epilepsy Market Drivers
Table 17. Epilepsy Market Challenges
Table 18. Epilepsy Market Restraints
Table 19. Global Epilepsy Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Epilepsy Market Share by Players (2018-2023)
Table 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy as of 2022)
Table 22. Ranking of Global Top Epilepsy Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Epilepsy Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Epilepsy Product Solution and Service
Table 26. Date of Enter into Epilepsy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Epilepsy Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Epilepsy Revenue Market Share by Type (2018-2023)
Table 30. Global Epilepsy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Epilepsy Revenue Market Share by Type (2024-2029)
Table 32. Global Epilepsy Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Epilepsy Revenue Market Share by Application (2018-2023)
Table 34. Global Epilepsy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Epilepsy Revenue Market Share by Application (2024-2029)
Table 36. North America Epilepsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Epilepsy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Epilepsy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Epilepsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Epilepsy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Epilepsy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Epilepsy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Epilepsy Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Epilepsy Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Epilepsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Epilepsy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Epilepsy Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Epilepsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Epilepsy Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Epilepsy Market Size by Country (2024-2029) & (US$ Million)
Table 51. LivaNova Company Detail
Table 52. LivaNova Business Overview
Table 53. LivaNova Epilepsy Product
Table 54. LivaNova Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 55. LivaNova Recent Development
Table 56. Johnson & Johnson Services Company Detail
Table 57. Johnson & Johnson Services Business Overview
Table 58. Johnson & Johnson Services Epilepsy Product
Table 59. Johnson & Johnson Services Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Services Recent Development
Table 61. Eisai Company Detail
Table 62. Eisai Business Overview
Table 63. Eisai Epilepsy Product
Table 64. Eisai Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 65. Eisai Recent Development
Table 66. GlaxoSmithKline PLC Company Detail
Table 67. GlaxoSmithKline PLC Business Overview
Table 68. GlaxoSmithKline PLC Epilepsy Product
Table 69. GlaxoSmithKline PLC Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline PLC Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Epilepsy Product
Table 74. Pfizer Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. UCB SA Company Detail
Table 77. UCB SA Business Overview
Table 78. UCB SA Epilepsy Product
Table 79. UCB SA Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 80. UCB SA Recent Development
Table 81. Medtronic PLC (Ireland) Company Detail
Table 82. Medtronic PLC (Ireland) Business Overview
Table 83. Medtronic PLC (Ireland) Epilepsy Product
Table 84. Medtronic PLC (Ireland) Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 85. Medtronic PLC (Ireland) Recent Development
Table 86. NeuroPace Company Detail
Table 87. NeuroPace Business Overview
Table 88. NeuroPace Epilepsy Product
Table 89. NeuroPace Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 90. NeuroPace Recent Development
Table 91. Novartis AG Company Detail
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Epilepsy Product
Table 94. Novartis AG Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. GW Pharmaceuticals Company Detail
Table 97. GW Pharmaceuticals Business Overview
Table 98. GW Pharmaceuticals Epilepsy Product
Table 99. GW Pharmaceuticals Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 100. GW Pharmaceuticals Recent Development
Table 101. Abbott Laboratories Company Detail
Table 102. Abbott Laboratories Business Overview
Table 103. Abbott Laboratories Epilepsy Product
Table 104. Abbott Laboratories Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 105. Abbott Laboratories Recent Development
Table 106. Sanofi Company Detail
Table 107. Sanofi Business Overview
Table 108. Sanofi Epilepsy Product
Table 109. Sanofi Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 110. Sanofi Recent Development
Table 111. Sunovion Pharmaceuticals Company Detail
Table 112. Sunovion Pharmaceuticals Business Overview
Table 113. Sunovion Pharmaceuticals Epilepsy Product
Table 114. Sunovion Pharmaceuticals Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 115. Sunovion Pharmaceuticals Recent Development
Table 116. Bausch Health Company Detail
Table 117. Bausch Health Business Overview
Table 118. Bausch Health Epilepsy Product
Table 119. Bausch Health Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 120. Bausch Health Recent Development
Table 121. Takeda Company Detail
Table 122. Takeda Business Overview
Table 123. Takeda Epilepsy Product
Table 124. Takeda Revenue in Epilepsy Business (2018-2023) & (US$ Million)
Table 125. Takeda Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Epilepsy Market Share by Type: 2022 VS 2029
Figure 3. Partial/focal Seizure Features
Figure 4. Generalized Seizure Features
Figure 5. Myoclonus Misses Features
Figure 6. Negative Myoclonus Features
Figure 7. Eyelid Myoclonus Features
Figure 8. Laughter Features
Figure 9. Others Features
Figure 10. Global Epilepsy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Epilepsy Market Share by Application: 2022 VS 2029
Figure 12. Hospitals Case Studies
Figure 13. Neurology Centers Case Studies
Figure 14. Home Care Settings Case Studies
Figure 15. Ambulatory Surgical Centers Case Studies
Figure 16. Others Case Studies
Figure 17. Epilepsy Report Years Considered
Figure 18. Global Epilepsy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Epilepsy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Epilepsy Market Share by Region: 2022 VS 2029
Figure 21. Global Epilepsy Market Share by Players in 2022
Figure 22. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Epilepsy Revenue in 2022
Figure 24. North America Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Epilepsy Market Share by Country (2018-2029)
Figure 26. United States Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Europe Epilepsy Market Share by Country (2018-2029)
Figure 30. Germany Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Asia-Pacific Epilepsy Market Share by Region (2018-2029)
Figure 38. China Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Japan Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. India Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Australia Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Latin America Epilepsy Market Share by Country (2018-2029)
Figure 46. Mexico Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Brazil Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Epilepsy Market Share by Country (2018-2029)
Figure 50. Turkey Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Epilepsy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. LivaNova Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 53. Johnson & Johnson Services Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 54. Eisai Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 55. GlaxoSmithKline PLC Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 57. UCB SA Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 58. Medtronic PLC (Ireland) Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 59. NeuroPace Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 61. GW Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 62. Abbott Laboratories Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 63. Sanofi Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 64. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 65. Bausch Health Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 66. Takeda Revenue Growth Rate in Epilepsy Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed